Tracking Pathogens in Real Time to Stop Outbreaks

Tracking Pathogens in Real Time to Stop Outbreaks

Monday, April 12

 

Supramap, a powerful new web-based application that tracks pathogens in time and space as they evolve, can help public health officials and national security experts predict and respond to outbreaks of infectious diseases. The program was officially announced in a paper in Cladistics.

"This tool has a lot of predictive power," says Ward Wheeler, curator in the Division of Invertebrate Zoology at the Museum. "If the movement of a pathogen is related to bird flyways, for example, and those routes are shifting because of something like climate change, we can predict where the disease might logically emerge next."

Operating on parallel programming on high-performance computing systems at Ohio State University and the Ohio Supercomputer Center, Supramap allows any user to input raw genetic sequences of a pathogen's strains and build an evolutionary tree based on mutations. The branches are projected onto the globe with pop-up windows to show how strains mutate over space and time and infect new hosts.

In the research paper, Wheeler and colleagues test Supramap's capability on recent strains of avian influenza (H5N1). The evolutionary tree (see the image), based on 239 sequences of a specific gene, polymerase basic 2, shows that host shifts are highly correlated with a specific gene mutation that allows avian viruses to adapt to mammalian hosts.

"We package the tools in an easy-to-use web-based application so that you don't need a Ph.D. in evolutionary biology and computer science to understand the trajectory and transmission of a disease," says Daniel A. Janies, first author of the paper and an associate professor at Ohio State University.

Suggested Articles

In this week's EuroBiotech Report, AstraZeneca plans 2020 lupus filing, Roche's SMA trial hits endpoint and Kiadis cuts staff in R&D pivot.

In our EuroBiotech roundup this week, NEC and Vaximm ink cancer vaccine pact, Compugen posts cancer data and Lunac raises cash.

Biotech venture fund ATAI Life Sciences has partnered with artificial intelligence drug discovery specialist Cyclica to form a new JV.